Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
Tryptamine Therapeutics (ASX:TYP) has finished dosing the first patient with psilocin using…
Tryptamine Therapeutics Limited (ASX:TYP)
About Tryptamine Therapeutics Limited
Key Information
TYP In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 01/07/2024 | Price Sensitive PS Maiden dosing of TRP-8803 completed in global first | 241.09KB | 562 |
| 26/06/2024 | Dr Robin Carhart-Harris renews role as SAB Chair | 158.27KB | 246 |
| 19/06/2024 | Appointment product registration & reimbursement strategy | 275.76KB | 277 |
| 17/06/2024 | Change of Director's Interest Notice - JC | 4.62KB | 256 |
| 07/06/2024 | Details of Company Address | 212.22KB | 301 |
| 07/06/2024 | Change of Director's Interest Notice - JC | 4.62KB | 279 |
| 06/06/2024 | Change of Director's Interest Notice - JC | 4.62KB | 662 |
| 04/06/2024 | Change of Director's Interest Notice - JC | 4.61KB | 489 |